HEMOSTASIS COAGULATION RESEARCH REAGENTS DEFICIENT PLASMAS CONGENITAL DEFICIENT PLASMAS (BOTTLES)
Human Factor VIII congenital deficient plasma (severe <1%)
Plasma from a human donor with congenital FVIII deficiency.
Anticoagulant : 3.2 % sodium citrate.
Packaging in bottle. The minimum packaged volume is 50 mL. The price offer is based on the volume requested.
Advantages
Minimize test time.
Ready to use.
Informations
Factor VIII is a glycoprotein mainly synthesized by the liver. It circulates in the plasma in the form bound to VWF which protects it from rapid proteolytic degradation.
It is activated by FXa or thrombin in FVIIIa which will complex with FIXa in the presence of phospholipids to activate FX in FXa.
A patient who is deficient in FVIII has hemophilia A.
Documentation
Download the product sheetPrice list, safety data sheets and notices are accessible to our registered customers.
References
6-PPD08C-S | Vial | Minimum 50 mL |